COX-2 is widely expressed in metaplastic epithelium in pulmonary fibrous disorders

American Journal of Clinical Pathology

Volumn 126, Issue 5, 2006, Pages 717-724

  Lappi Blanco, Elisa ^a   Kaarteenaho Wiik, Rütta ^a   Maasilta, Paula K ^b   Anttila, Sisko ^d   Pääkkö, Paavo ^c   Wolff, Henrik J ^b,d  

^a UNIVERSITY OF OULU   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

COX 2; Cryptogenic organizing pneumonia; Cyclooxygenase 2; Epithelium; Idiopathic pulmonary fibrosis; IPF; Pulmonary fibrosis; Usual interstitial pneumonia

Indexed keywords

CYCLOOXYGENASE 2; PROSTAGLANDIN E2;

ARTICLE; ASBESTOSIS; BRONCHIOLITIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOGENIC ORGANIZING PNEUMONIA; DESQUAMATIVE PNEUMONIA; FATALITY; FIBROBLAST; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; LUNG INJURY; LUNG LAVAGE; MESENCHYME CELL; MYOFIBROBLAST; ORGANIZING PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ASBESTOSIS; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CYCLOOXYGENASE 2; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG DISEASES, INTERSTITIAL; MEMBRANE PROTEINS; METAPLASIA; PULMONARY FIBROSIS;

EID: 33750721691     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/PFGXCLNG2N17PJX9     Document Type: Article

References (33)

1. American Thoracic Society, European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277-304.
2. Travis WD, Colby TV, Koss MN, et al, eds. Occupational lung diseases and pneumoconioses. In: Nonneoplastic Disorders of the Lower Respiratory Tract. Washington, DC: American Registry of Pathology and Armed Forces Institute of Pathology; 2002:815-823. Atlas of Nontumor Pathology; Series 1, Fascicle 2.
3. Oksa P, Klockars M, Karjalainen A, et al. Progression of asbestosis predicts lung cancer. Chest. 1998;113:1517-1521.
4. Sharma OP, Lamb C. Cancer in interstitial pulmonary fibrosis and sarcoidosis. Curr Opin Pulm Med. 2003;9:398-401.
5. Murakami M, Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res. 2004;43:3-35.
6. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J. 1998;12:1063-1073.
7. Gilroy DW, Colville-Nash PR. New insights into the role of COX-2 in inflammation. J Mol Med. 2000;78:121-129.
8. Norman RJ. Reproductive consequences of COX-2 inhibition. Lancet. 2001;358:1287-1288.
9. Lassus P, Wolff H, Andersson S. Cyclooxygenase-2 in human perinatal lung. Pediatr Res. 2000;47:602-605.
10. Ito Y, Yoshida H, Nakano K, et al. Cyclooxygenase-2 expression in thyroid neoplasms. Histopathology. 2003;42:492-497.
11. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 1995;55:3785-3789.
12. Wolff H, Saukkonen K, Anttila S, et al. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 1998;58:4997-5001.
13. Jenkins G, Hart SL, Hodges RJ, et al. Cyclooxygenase-2 overexpression, using an integrin-targeted delivery system (the LID vector), inhibits fibroblast proliferation in vitro and leads to increased prostaglandin E(2), in the lung. Chest. 2002;121(3 suppl):102S-104S.
14. Kolodsick JE, Peters-Golden M, Larios J, et al. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E-prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol. 2003;29:537-544.
15. Keerthisingam CB, Jenkins RG, Harrison NK, et al. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol. 2003;158:1411-1422.
16. Xaubet A, Roca-Ferrer J, Pujols L, et al. Cyclooxygenase-2 is upregulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:35-42.
17. Borok Z, Gillissen A, Buhl R, et al. Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis. 1991;144:1080-1084.
18. Hodges RJ, Jenkins RG, Wheeler-Jones CPD, et al. Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E2 production. Am J Pathol. 2004;165:1663-1676.
19. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134:136-151.
20. Adamson IYR, Bowden DH. The type 2 cell as progenitor of alveolar epithelial regeneration: a cytodynamic study in mice after exposure to oxygen. Lab Invest. 1974;30:35-42.
21. Kawanami O, Ferrans VJ, Crystal RG. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest. 1982;46:39-53.
22. Hinata N, Takemura T, Ikushima S, et al. Phenotype of regenerative epithelium in idiopathic interstitial pneumonias. J Med Dent Sci. 2003;50:213-224.
23. Albera C, Polak JM, Janes S, et al. Repopulation of human pulmonary epithelium by bone marrow cells: a potential means to promote repair. Tissue Eng. 2005;11:1115-1121.
24. Päiväniemi OE, Maasilta PK, Alho HS, et al. Cyclooxygenase-2 expression in experimental post-transplant obliterative bronchiolitis. J Pathol. 2004;204:340-348.
25. Wilbom J, Crofford LJ, Burdick MD, et al. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest. 1995;95:1861-1868.
26. Lama V, Moore BB, Christensen P, et al. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am J Respir Cell Mol Biol. 2002;27:752-758.
27. Moore BB, Peters-Golden M, Christensen PJ, et al. Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. Am J Physiol Lung Cell Mol Physiol. 2003;284:L342-L349.
28. Charbeneau RP, Christensen PJ, Chrisman CJ, et al. Impaired synthesis of prostaglandin E2 by lung fibroblasts and alveolar epithelial cells from GM-CSF-/- mice: implications for fibroproliferation. Am J Physiol Lung Cell Mol Physiol. 2003;284:L1103-L1111.
29. Moore BB, Ballinger MN, White ES, et al. Bleomyein-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2. J Immunol. 2005;174:5644-5649.
30. 2 regulates wound closure in airway epithelium. Am J Physiol Lung Cell Mol Physiol 2001;28:L421-L431.
31. Amico C, Yakimov M, Catania MV, et al. Differential expression of cyclooxygenase-1 and cyclooxygenase-2 in the cornea during wound healing. Tissue Cell. 2004;36:1-12.
32. Ozaki T, Rennard SI, Crystal RG. Cyclooxygenase metabolites are compartmentalized in the human lower respiratory tract. J Appl Physiol. 1987;62:219-222.
33. Lappi-Blanco E, Kaarteenaho-Wiik R, Salo S, et al. Laminin-5 γ2 chain in cryptogenic organizing pneumonia and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2004;169:27-33.